Aspect Biosystems is pioneering bioprinted tissue therapeutics to treat currently incurable diseases. Their full-stack platform integrates proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design to create next-generation cell therapies. These bioprinted tissues aim to replace, repair, or supplement biological functions, potentially transforming the treatment of diseases such as type 1 diabetes and liver diseases. Aspect’s innovative approach ensures biologically functional, immune-protective, and implantable solutions.